Your session is about to expire
← Back to Search
Treatment for Leukemia
N/A
Recruiting
Led By Jan Cerny, MD, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on average, indefinite, or until death of participant
Awards & highlights
Summary
The collection of Blood and/or Bone Marrow from patients with blood disorders, blood cell malignancies and associated conditions will serve as a convenient and comprehensive source of tissue to give us further information about the differences between normal blood cells and blood cells of affected individuals. This will be an invaluable asset for understanding the biology of blood disorders. The collected samples will be used by investigators for studies including immunology, molecular biology and genetics to name a few.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ on average, indefinite, or until death of participant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on average, indefinite, or until death of participant
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The study is designed to collect blood and bone marrow from patients with various hematological diseases.
Secondary study objectives
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth in Patients With Malignancy or Hematologic Disorders
Find a Location
Who is running the clinical trial?
University of Massachusetts, WorcesterLead Sponsor
356 Previous Clinical Trials
991,215 Total Patients Enrolled
2 Trials studying Leukemia
4 Patients Enrolled for Leukemia
Jan Cerny, MD, PhDPrincipal Investigator - University of Massachusetts, Worcester
UMass Memorial Medical Center-University Campus
Charles University V Praze (Medical School)
University Of Ma Medical Sch (Residency)
2 Previous Clinical Trials
4 Total Patients Enrolled
2 Trials studying Leukemia
4 Patients Enrolled for Leukemia
Share this study with friends
Copy Link
Messenger